China SXT Pharmaceuticals Inc
sxtchina.comWhat Do They Do?
Manufactures and sells traditional Chinese medicine products to hospitals and pharmaceutical distributors in China.
20-F for FY2026, filed Jul 1, 2026
How Do They Make Money?
Hospitals and pharmaceutical distributors pay for traditional Chinese medicine products, typically when goods ship or are delivered; some customers prepay against purchase orders.
20-F for FY2026, filed Jul 1, 2026Our major customers are hospitals, especially TCM hospitals, primarily in the Jiangsu province in China. Another substantial part of our…View ↗
Our major customers are hospitals, especially TCM hospitals primarily in the Jiangsu provinces in China and pharmaceutical wholesalers. The…View ↗
Revenue is recognized when control of promised goods is transferred to the Company’s customers in an amount of consideration of which the…View ↗
The contract liabilities of the Company consist of advance payments from customers. The contract liabilities are reported in a net position…View ↗
-
20-F for FY2026, filed Jul 1, 2026
FY2026 revenue by product or service ↗
$1.1M
-
20-F for FY2026, filed Jul 1, 2026
$1.1M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Advanced TCMP
Sold outright
|
4.4% |
Advanced TCMP, FY2026
$49.5K Sources
|
Sold outright |
|
Regular TCMP
Sold outright
20-F for FY2026, filed Jul 1, 2026 |
95% |
Regular TCMP, FY2026
$1.1M Sources
|
Sold outright |
|
Others
Sold outright
|
0.6% |
Others, FY2026
$7.1K Sources
|
Sold outright |
Who Are Their Customers?
Hospitals, especially traditional Chinese medicine hospitals, are major customers; pharmaceutical wholesalers also buy and distribute products to hospitals and other healthcare distributors.
20-F for FY2026, filed Jul 1, 2026
Do Revenues Turn Into Profits?
No. It lost $6.2M in FY2026.
20-F for FY2026, filed Jul 1, 2026
How Are They Changing?
Shrinking. Revenue fell 56% in 4 years, from $2.6M in FY2022 to $1.1M in FY2026, about 19% a year.
Who Do They Compete With?
Competes with Kangmei, CTCM, and Xiangxue
20-F for FY2026, filed Jul 1, 2026Numerous competitors nationwide, including Kangmei, CTCM and Xiangxue, participate in the sale of Chinese medicinal herbs and TCMPs; among…View ↗
Loading...
